18.12.2008Wyeth Pharmaceuticals acquires Thiakis in a transaction worth up to £100m
Advent Venture Partners announces successful exit from portfolio company Thiakis in a transaction worth up to £100 million.
Press Release21.11.2008Infinity Pharmaceuticals strikes major alliance to fully fund promising pipelinePress Release
28.08.2008Algeta Reports Positive Headline Phase II Data on Pain Palliation with AlpharadinPress Release